Last quarter (Q3 2025), Cross River Ventures's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Cross River Ventures's net income was $-189.44K. See Cross River Ventures’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jan 24	Jan 23	Jan 22	Jan 21	Jan 20
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ -65.89K	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 920.68K	$ 676.50K	$ -1.96M	$ ―	$ 1.51M	$ 91.21K
Operating Income	$ -986.58K	$ -676.50K	$ 1.96M	$ ―	$ -1.51M	$ -91.21K
Net Non Operating Interest Income Expense	$ 1.29K	$ 5.07K	$ 2.29K	$ ―	$ -331.00	$ ―
Other Income Expense	$ -513.21K	$ 33.57K	$ -227.01K	$ ―	$ -46.80K	$ ―
Pretax Income	$ -2.56M	$ -2.79M	$ 1.42M	$ ―	$ -1.56M	$ -91.21K
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -2.56M	$ -2.79M	$ 1.42M	$ ―	$ -1.56M	$ -91.21K
Basic EPS	$ -0.03	$ -0.03	$ -0.09	$ ―	$ -0.15	$ -0.01
Diluted EPS	$ -0.03	$ -0.03	$ -0.09	$ ―	$ -0.15	$ -0.01
Basic Average Shares	$ 498.92M	$ 88.33M	$ 59.00M	$ ―	$ 10.56M	$ 8.25M
Diluted Average Shares	$ 498.92M	$ 88.33M	$ 59.00M	$ ―	$ 10.56M	$ 8.25M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 497.20K	$ 676.50K	$ -1.96M	$ 2.70M	$ -1.51M	$ -91.21K
Net Income From Continuing And Discontinued Operation	$ -2.56M	$ -2.79M	$ 1.42M	$ ―	$ -1.56M	$ -91.21K
Normalized Income	$ 184.38K	$ 90.64K	$ 1.82M	$ -1.95M	$ -1.09M	$ -91.21K
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -2.56M	$ -2.79M	$ 1.42M	$ -2.65M	$ -1.56M	$ -91.21K
EBITDA	$ -2.56M	$ -2.79M	$ 1.42M	$ -2.65M	$ -1.56M	$ ―

Currency in USD

Cross River Ventures Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing